Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
All Eyes on Gen Z as They Enter the Workforce
Cleveland Clinic Starts Fundraising Effort for New Hospital in West Palm Beach
Cultivating a Workforce in the Face of Skilled Trade Shortages
Prime Healthcare Acquires 8 Ascension Hospitals in Illinois
Charging Ahead: Incentives Driving EV Charging in Healthcare Facilities